Siebner H, Weber W
Osterr Z Onkol. 1976 May;3(1-2):8-26.
132 patients with advanced solid malignomas were treated with a combination of four cytostatic drugs (vinblastine, amethopterine, 5-fluorouracil and cyclophosphamid) given on one day. This was repeated once every 2-3 weeks. In every case the diagnosis was made histologically and the tumour was staged according to the TNM-system. The treatment of breast and ovarian cancer brought the best results, improved by a synchronisation therapy. Good results were achieved also in the treatment of special kind of sarcomas and of carcinoma of the urine bladder. The general condition of patients with colon carcinoma could be improved in about 30%. Only one patient died by drug-induced pancytopenia, otherwise severe side-effects were not noted. Before beginning the therapy the cell-mediated immunity of 31 patients was tested by skin-tests with tuberkulin purified protein derivative (PPD) and dinitrochlorbenzole (DNCB). Before and during cytostatic therapy PPD reactions were proven by 23 patients. In accordance to other authors we found that cell-mediated immunity is decreased in the advanced stage of malignoma. Further we noted that delayed hypersensitivity and the number of lymphocytes and monocytes in peripherel blood are important to prognosis and course in patients with cancer.
132例晚期实体恶性肿瘤患者接受了四种细胞抑制药物(长春碱、氨甲蝶呤、5-氟尿嘧啶和环磷酰胺)联合一日给药治疗。每2至3周重复一次。每例均经组织学确诊,并根据TNM系统对肿瘤进行分期。乳腺癌和卵巢癌的治疗效果最佳,同步治疗可使其得到改善。特殊类型的肉瘤和膀胱癌的治疗也取得了良好效果。结肠癌患者的一般状况约30%得到改善。仅1例患者死于药物性全血细胞减少症,未观察到其他严重副作用。在开始治疗前,对31例患者进行了结核菌素纯蛋白衍生物(PPD)和二硝基氯苯(DNCB)皮肤试验,以检测其细胞介导免疫。在细胞抑制治疗前和治疗期间,23例患者的PPD反应得到证实。与其他作者一致,我们发现恶性肿瘤晚期患者的细胞介导免疫降低。此外,我们注意到迟发型超敏反应以及外周血中淋巴细胞和单核细胞的数量对癌症患者的预后和病程很重要。